Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma

The contact address for the TRACERx consortium is ctc.tracerx@ucl.ac.uk. D.B. and Y.-H.L. designed the experiments, performed the bioinformatics analyses and wrote the manuscript. N.J.B., J.H., Y.W., D.A.M., T.K., K.G. and W.L. provided early feedback and helped to direct the avenues of bioinformatics analysis. S.V., C.N.-L., N.M. and S.W. performed sample collection and RNA extraction and helped with data interpretation. A.M.F., M.H. and E.C. performed data processing and helped with data interpretation. S.d.C.T., P.E., A.M., D.M.S., O.O., D.L., J. Mattson, A.L., P.M., J. Moldvay, Z.M., B.D., J.F., J.N., J.D., Z.S. and N.K. provided access to additional datasets and helped with data interpretation. A.H. provided statistical advice. M.J.-H. designed the TRACERx study protocols and helped to analyze the clinical characteristics of the patients. D.B. and C.S. conceived the project, acquired funding, supervised the study and edited the manuscript. All authors reviewed and approved the manuscript.

留言 (0)

沒有登入
gif